The finding that CD8+ Tregs induced ex vivo with TGF-β have therapeutic functionality on cGVHD lupus nephritis stimulated us to further investigate the underlying molecular mechanisms responsible for the function of these iTregs. This evidence concerns the gene CD8A and lupus nephritis.